AGM, EGM Calendar |
Tuesday May 17 |
Standard Life |
Cenkos Securities |
Aldermore Group |
Metminco |
Sportech |
Rockhopper Exploration |
Journey Group |
Assetco |
Burford Capital |
Fishing Republic |
Hill & Smith Holdimgs |
S&U |
Toumaz |
Charles Taylor |
Impax Environmental Markets |
Polymetal International |
Regus |
EG Solutions |
Wednesday, May 18 |
UBM |
Jupiter Fund Management |
Antofagasta |
Paddy Power Betfair |
Circassia Pharmaceuticals |
ProPhotonix |
STM Group |
Satellite Solutions Worldwide |
CPPGroup |
Vitec Group |
Safecharge International |
European REIT |
Panmure Gordon & Co |
Marshalls |
Circle Holdings |
Bankers Petroleum |
Frenkel Topping Group |
Johnston Press |
Stilo International |
Foxtons Group |
Xaar |
Rathbone Brothers |
Skyepharma |
Chesnara |
Playtech |
Zotefoams |
Thursday, May 19 |
Next |
Merlin Entertainments |
Informa |
Balfour Beatty |
Prudential |
StatPro Group |
Computacenter |
PPHE Hotel Group |
ProPhotonix |
Sherborne Investors |
Cineworld Group |
Learning Technologies |
Revolymer |
Crossrider |
Science Group |
Safestyle UK |
GLI Finance |
Staffline Group |
Riverstone Energy |
Gamma Communications |
Glencore |
Petrofac |
HaloSource (re recreational water business sale) |
Ferrexpo |
North Midland Construction |
Portmeiron Group |
Concurrent Technology |
Game Digital (re loan facility with Lajedosa Investments) |
Conviviality (re acquisition of Bibendum PLB & proposed placing) |
Exova Group |
LMS Capital |
PV Crystalox Solar |
Hiscox |
Friday, May 20 |
Spectris |
Moss Bros Group |
Applegreen |
Richland Resources |
Snacktime |
Hydrogen Group |
John Menzies |
Hochschild Mining |
Vislink |
Headlam Group |
Baillie Gifford Shin Nippon |
Spectris |
Monday, May 23 |
Restore |
Stock Spirits Group |
Noricum Gold |
Nasstar |
4D Pharma |
Hvivo |
Plant Healthcare |
Synety Group |
Vertu Capital |
Copyright 2016 Alliance News Limited. All Rights Reserved. |
Sunday share tips: hVivo and On the Beach
(Sharecast News) - Drug-testing specialist hVivo was one of the top tips for 2023 from The Daily Mail's Midas column, but the paper still reckons there's further to go despite the stock doubling in price over the year.
Read more